Baroda BNP Paribas Health & Wellness Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Baroda BNP Paribas Health & Wellness Growth Direct Plan

NAV
₹9.8681
+0.18%
(12 Sep)
AUM
637 Cr
TER
0.43%
Risk
Very High Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+4.3%
+1.4%
-3.0%
-3.5%
NA
3Y
+29.5%
+29.4%
+30.0%
+30.1%
NA
5Y
+22.9%
+30.4%
+31.9%
+30.3%
NA
ALL
+22.9%
+18.4%
+11.9%
+16.9%
-1.3%
VOL
15.3%
16.3%
20.2%
19.7%
10.0%
TER
1.0%
0.5%
0.8%
0.9%
0.4%
AUM
₹6,162 Cr
₹7,509 Cr
₹5,179 Cr
₹1,341 Cr
₹637 Cr
INFO
1.50
1.13
0.59
0.86
-0.13
See fund holdings as of 31st Jul
Top holdings
Clearing Corporation Of India Ltd
13.5%
Sun Pharmaceuticals Industries Ltd
12.1%
Net Receivables / (Payables)
6.8%
Divi's Laboratories Ltd
5.9%
Apollo Hospitals Enterprise Ltd
5.6%
Mankind Pharma Ltd
5.5%
Cipla Ltd
5.2%
Max Healthcare Institute Ltd Ordinary Shares
4.8%
Fortis Healthcare Ltd
4.0%
Gland Pharma Ltd
3.6%
Top industry exposure
Healthcare
90.6%
Financial Services
2.7%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
5%
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund manager(s)
Sanjay Chawla

FAQs